{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:51:25Z","timestamp":1785372685723,"version":"3.55.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00118"],"award-info":[{"award-number":["PI18\/00118"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS2015\/00780"],"award-info":[{"award-number":["FIS2015\/00780"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00118"],"award-info":[{"award-number":["PI18\/00118"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI2016\/01"],"award-info":[{"award-number":["PI2016\/01"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2017\/BMD-3700"],"award-info":[{"award-number":["S2017\/BMD-3700"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["CIVP16A1825"],"award-info":[{"award-number":["CIVP16A1825"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In Alzheimer\u2019s disease (AD) amyloid-\u03b2 (A\u03b2) deposits may cause impairments in choroid plexus, a specialised brain structure which forms the blood\u2013cerebrospinal fluid (CSF) barrier. We previously carried out a mass proteomic-based study in choroid plexus from AD patients and we found several differentially regulated proteins compared with healthy subjects. One of these proteins, annexin A5, was previously demonstrated implicated in blocking A\u03b2-induced cytotoxicity in neuronal cell cultures. Here, we investigated the effects of annexin A5 on A\u03b2 toxicity in choroid plexus. We used choroid plexus tissue samples and CSF from mild cognitive impairment (MCI) and AD patients to analyse A\u03b2 accumulation, cell death and annexin A5 levels compared with control subjects. Choroid plexus cell cultures from rats were used to analyse annexin A5 effects on A\u03b2-induced cytotoxicity. AD choroid plexus exhibited progressive reduction of annexin A5 levels along with progressive increased A\u03b2 accumulation and cell death as disease stage was higher. On the other hand, annexin A5 levels in CSF from patients were found progressively increased as the disease stage increased in severity. In choroid plexus primary cultures, A\u03b2 administration reduced endogenous annexin A5 levels in a time-course dependent manner and simultaneously increased annexin A5 levels in extracellular medium. Annexin A5 addition to choroid plexus cell cultures restored the A\u03b2-induced impairments on autophagy flux and apoptosis in a calcium-dependent manner. We propose that annexin A5 would exert a protective role in choroid plexus and this protection is lost as A\u03b2 accumulates with the disease progression. Then, brain protection against further toxic insults would be jeopardised.<\/jats:p>","DOI":"10.1038\/s41598-020-66177-5","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T10:03:15Z","timestamp":1591783395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Annexin A5 prevents amyloid-\u03b2-induced toxicity in choroid plexus: implication for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9322-8933","authenticated-orcid":false,"given":"Fernando","family":"Bartolome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Krzyzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"de la Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Antequera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Spuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Villarejo-Galende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Rabano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-3245","authenticated-orcid":false,"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-5478","authenticated-orcid":false,"given":"Alberto","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-8754","authenticated-orcid":false,"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Y.","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6504-4579","authenticated-orcid":false,"given":"Eva","family":"Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"66177_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"66177_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert, M. & Spillantini, M. G. A century of Alzheimer\u2019s disease. Science 314, 777\u2013781 (2006).","journal-title":"Science"},{"key":"66177_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-27","volume":"6","author":"H Zheng","year":"2011","unstructured":"Zheng, H. & Koo, E. H. Biology and pathophysiology of the amyloid precursor protein. Mol. neurodegeneration 6, 27 (2011).","journal-title":"Mol. neurodegeneration"},{"key":"66177_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-63","volume":"6","author":"RM Koffie","year":"2011","unstructured":"Koffie, R. M., Hyman, B. T. & Spires-Jones, T. L. Alzheimer\u2019s disease: synapses gone cold. Mol. neurodegeneration 6, 63 (2011).","journal-title":"Mol. neurodegeneration"},{"key":"66177_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","volume":"924","author":"DJ Selkoe","year":"2000","unstructured":"Selkoe, D. J. Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 924, 17\u201325 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"66177_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neurobiolaging.2007.01.008","volume":"29","author":"MO Dietrich","year":"2008","unstructured":"Dietrich, M. O. et al. Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol. Aging 29, 902\u2013912, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.01.008 (2008).","journal-title":"Neurobiol. Aging"},{"key":"66177_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.neurobiolaging.2008.08.017","volume":"31","author":"T Vargas","year":"2010","unstructured":"Vargas, T. et al. Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis. Neurobiol. Aging 31, 1569\u20131581 (2010).","journal-title":"Neurobiol. Aging"},{"key":"66177_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainres.2006.12.022","volume":"1138","author":"JS Crossgrove","year":"2007","unstructured":"Crossgrove, J. S., Smith, E. L. & Zheng, W. Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers. Brain Res. 1138, 187\u2013195, https:\/\/doi.org\/10.1016\/j.brainres.2006.12.022 (2007).","journal-title":"Brain Res."},{"key":"66177_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0169-328x(95)00180-z","volume":"35","author":"RN Kalaria","year":"1996","unstructured":"Kalaria, R. N., Premkumar, D. R., Pax, A. B., Cohen, D. L. & Lieberburg, I. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer\u2019s disease. Brain Res. Mol. Brain Res 35, 58\u201368, https:\/\/doi.org\/10.1016\/0169-328x(95)00180-z (1996).","journal-title":"Brain Res. Mol. Brain Res"},{"key":"66177_CR10","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1111\/ejn.12159","volume":"37","author":"F Liu","year":"2013","unstructured":"Liu, F. et al. gamma-secretase binding sites in aged and Alzheimer\u2019s disease human cerebrum: the choroid plexus as a putative origin of CSF Abeta. Eur. J. Neurosci. 37, 1714\u20131725, https:\/\/doi.org\/10.1111\/ejn.12159 (2013).","journal-title":"Eur. J. Neurosci."},{"key":"66177_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/PL00007412","volume":"99","author":"JM Serot","year":"2000","unstructured":"Serot, J. M., Bene, M. C., Foliguet, B. & Faure, G. C. Morphological alterations of the choroid plexus in late-onset Alzheimer\u2019s disease. Acta neuropathologica 99, 105\u2013108 (2000).","journal-title":"Acta neuropathologica"},{"key":"66177_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/jad-2012-111964","volume":"30","author":"JM Serot","year":"2012","unstructured":"Serot, J. M., Zmudka, J. & Jouanny, P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer\u2019s disease. J. Alzheimer\u2019s disease: JAD. 30, 17\u201326, https:\/\/doi.org\/10.3233\/jad-2012-111964 (2012).","journal-title":"J. Alzheimer\u2019s disease: JAD."},{"key":"66177_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00401-009-0574-4","volume":"118","author":"E Perez-Gracia","year":"2009","unstructured":"Perez-Gracia, E., Blanco, R., Carmona, M., Carro, E. & Ferrer, I. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer\u2019s disease. Acta neuropathologica 118, 497\u2013504 (2009).","journal-title":"Acta neuropathologica"},{"key":"66177_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/1097-0029(20010101)52:1<31::AID-JEMT5>3.0.CO;2-T","volume":"52","author":"JE Preston","year":"2001","unstructured":"Preston, J. E. Ageing choroid plexus-cerebrospinal fluid system. Microsc. Res. Tech. 52, 31\u201337 (2001).","journal-title":"Microsc. Res. Tech."},{"key":"66177_CR15","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1242\/jcs.01245","volume":"117","author":"U Rescher","year":"2004","unstructured":"Rescher, U. & Gerke, V. Annexins\u2013unique membrane binding proteins with diverse functions. J. Cell Sci. 117, 2631\u20132639, https:\/\/doi.org\/10.1242\/jcs.01245 (2004).","journal-title":"J. Cell Sci."},{"key":"66177_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00001721-199202000-00003","volume":"3","author":"J Romisch","year":"1992","unstructured":"Romisch, J. et al. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul. Fibrinolysis 3, 11\u201317 (1992).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"66177_CR17","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/CCM.0b013e3182a63e01","volume":"42","author":"P Arnold","year":"2014","unstructured":"Arnold, P. et al. Recombinant human annexin A5 inhibits proinflammatory response and improves cardiac function and survival in mice with endotoxemia. Crit. care Med. 42, e32\u201341, https:\/\/doi.org\/10.1097\/CCM.0b013e3182a63e01 (2014).","journal-title":"Crit. care Med."},{"key":"66177_CR18","doi-asserted-by":"publisher","first-page":"10568","DOI":"10.1021\/bi900608m","volume":"48","author":"S Bedrood","year":"2009","unstructured":"Bedrood, S. et al. Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxicity. Biochemistry 48, 10568\u201310576, https:\/\/doi.org\/10.1021\/bi900608m (2009).","journal-title":"Biochemistry"},{"key":"66177_CR19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/S0196-9781(02)00060-8","volume":"23","author":"G Lee","year":"2002","unstructured":"Lee, G., Pollard, H. B. & Arispe, N. Annexin 5 and apolipoprotein E2 protect against Alzheimer\u2019s amyloid-beta-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site. Peptides 23, 1249\u20131263 (2002).","journal-title":"Peptides"},{"key":"66177_CR20","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.1523\/JNEUROSCI.3916-08.2008","volume":"28","author":"LW Hung","year":"2008","unstructured":"Hung, L. W. et al. Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J. neuroscience: Off. J. Soc. Neurosci. 28, 11950\u201311958 (2008).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"66177_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neurobiolaging.2009.02.018","volume":"32","author":"GD Ciccotosto","year":"2011","unstructured":"Ciccotosto, G. D. et al. Stereospecific interactions are necessary for Alzheimer disease amyloid-beta toxicity. Neurobiol. Aging 32, 235\u2013248 (2011).","journal-title":"Neurobiol. Aging"},{"key":"66177_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrm1661","volume":"6","author":"V Gerke","year":"2005","unstructured":"Gerke, V., Creutz, C. E. & Moss, S. E. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. reviews. Mol. Cell Biol. 6, 449\u2013461 (2005).","journal-title":"Nat. reviews. Mol. Cell Biol."},{"key":"66177_CR23","doi-asserted-by":"publisher","first-page":"9966","DOI":"10.1021\/bi3013559","volume":"51","author":"CE Creutz","year":"2012","unstructured":"Creutz, C. E., Hira, J. K., Gee, V. E. & Eaton, J. M. Protection of the membrane permeability barrier by annexins. Biochemistry 51, 9966\u20139983, https:\/\/doi.org\/10.1021\/bi3013559 (2012).","journal-title":"Biochemistry"},{"key":"66177_CR24","doi-asserted-by":"crossref","unstructured":"Domeij, H. et al. Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine. Prostaglandins Other Lipid Mediat (2013).","DOI":"10.1016\/j.prostaglandins.2013.01.004"},{"key":"66177_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/ATVBAHA.110.216747","volume":"31","author":"MM Ewing","year":"2011","unstructured":"Ewing, M. M. et al. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. Arterioscler. Thromb. Vasc. Biol. 31, 95\u2013101 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"66177_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/SHK.0000000000000370","volume":"44","author":"C Gu","year":"2015","unstructured":"Gu, C., Liu, M., Zhao, T., Zhai, L. & Wang, Y. Recombinant Human Annexin A5 Can Repair the Disrupted Cardiomyocyte Adherens Junctions in Endotoxemia. Shock 44, 83\u201389, https:\/\/doi.org\/10.1097\/SHK.0000000000000370 (2015).","journal-title":"Shock"},{"key":"66177_CR27","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/eurheartj\/ehm452","volume":"28","author":"L Hofstra","year":"2007","unstructured":"Hofstra, L. & Heymans, S. Annexin A5 and the failing heart; lost or found in translation? Eur. Heart J. 28, 2695\u20132696, https:\/\/doi.org\/10.1093\/eurheartj\/ehm452 (2007).","journal-title":"Eur. Heart J."},{"key":"66177_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00467-007-0606-z","volume":"23","author":"B Simsek","year":"2008","unstructured":"Simsek, B. et al. Urinary annexin V in children with nephrotic syndrome: a new prognostic marker? Pediatr. Nephrol. 23, 79\u201382, https:\/\/doi.org\/10.1007\/s00467-007-0606-z (2008).","journal-title":"Pediatr. Nephrol."},{"key":"66177_CR29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/1531-8257(199911)14:6<1008::AID-MDS1015>3.0.CO;2-E","volume":"14","author":"I Vermes","year":"1999","unstructured":"Vermes, I., Steur, E. N., Reutelingsperger, C. & Haanen, C. Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause. Mov. disorders: Off. J. Mov. Disord. Soc. 14, 1008\u20131010 (1999).","journal-title":"Mov. disorders: Off. J. Mov. Disord. Soc."},{"key":"66177_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnagi.2013.00015","volume":"5","author":"H Sohma","year":"2013","unstructured":"Sohma, H. et al. Evaluation of annexin A5 as a biomarker for Alzheimer\u2019s disease and dementia with lewy bodies. Front. aging Neurosci. 5, 15 (2013).","journal-title":"Front. aging Neurosci."},{"key":"66177_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/nen.0000000000000181","volume":"74","author":"A Krzyzanowska","year":"2015","unstructured":"Krzyzanowska, A. et al. Expression of regulatory proteins in choroid plexus changes in early stages of Alzheimer disease. J. neuropathology Exp. Neurol. 74, 359\u2013369, https:\/\/doi.org\/10.1097\/nen.0000000000000181 (2015).","journal-title":"J. neuropathology Exp. Neurol."},{"key":"66177_CR32","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/jnr.22427","volume":"88","author":"M Yamaguchi","year":"2010","unstructured":"Yamaguchi, M. et al. Investigation of annexin A5 as a biomarker for Alzheimer\u2019s disease using neuronal cell culture and mouse model. J. Neurosci. Res. 88, 2682\u20132692 (2010).","journal-title":"J. Neurosci. Res."},{"key":"66177_CR33","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1523\/JNEUROSCI.17-16-06142.1997","volume":"17","author":"AM Cataldo","year":"1997","unstructured":"Cataldo, A. M., Barnett, J. L., Pieroni, C. & Nixon, R. A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer\u2019s disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. The. J. neuroscience: Off. J. Soc. Neurosci. 17, 6142\u20136151 (1997).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"66177_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4161\/auto.6259","volume":"4","author":"RA Nixon","year":"2008","unstructured":"Nixon, R. A., Yang, D. S. & Lee, J. H. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4, 590\u2013599 (2008).","journal-title":"Autophagy"},{"key":"66177_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4161\/auto.5338","volume":"4","author":"DJ Klionsky","year":"2008","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151\u2013175 (2008).","journal-title":"Autophagy"},{"key":"66177_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4161\/auto.3678","volume":"3","author":"DJ Klionsky","year":"2007","unstructured":"Klionsky, D. J., Cuervo, A. M. & Seglen, P. O. Methods for monitoring autophagy from yeast to human. Autophagy 3, 181\u2013206 (2007).","journal-title":"Autophagy"},{"key":"66177_CR37","doi-asserted-by":"publisher","first-page":"39904","DOI":"10.1074\/jbc.M111.267583","volume":"286","author":"U Neniskyte","year":"2011","unstructured":"Neniskyte, U., Neher, J. J. & Brown, G. C. Neuronal death induced by nanomolar amyloid beta is mediated by primary phagocytosis of neurons by microglia. J. Biol. Chem. 286, 39904\u201339913 (2011).","journal-title":"J. Biol. Chem."},{"key":"66177_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.phrs.2015.05.007","volume":"99","author":"R Abeti","year":"2015","unstructured":"Abeti, R. & Abramov, A. Y. Mitochondrial Ca(2+) in neurodegenerative disorders. Pharmacol. research: Off. J. Italian Pharmacol. Soc. 99, 377\u2013381, https:\/\/doi.org\/10.1016\/j.phrs.2015.05.007 (2015).","journal-title":"Pharmacol. research: Off. J. Italian Pharmacol. Soc."},{"key":"66177_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1523\/jneurosci.4042-03.2004","volume":"24","author":"AY Abramov","year":"2004","unstructured":"Abramov, A. Y., Canevari, L. & Duchen, M. R. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. The. J. neuroscience: Off. J. Soc. Neurosci. 24, 565\u2013575, https:\/\/doi.org\/10.1523\/jneurosci.4042-03.2004 (2004).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"66177_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1196\/annals.1422.011","volume":"1108","author":"A Cederholm","year":"2007","unstructured":"Cederholm, A. & Frostegard, J. Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann. N. Y. Acad. Sci. 1108, 96\u2013103 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"66177_CR41","doi-asserted-by":"publisher","first-page":"74263","DOI":"10.18632\/oncotarget.19392","volume":"8","author":"HS Baek","year":"2017","unstructured":"Baek, H. S. et al. Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-zeta-nuclear factor-kappaB signaling pathway in prostate cancer cells. Oncotarget 8, 74263\u201374275, https:\/\/doi.org\/10.18632\/oncotarget.19392 (2017).","journal-title":"Oncotarget"},{"key":"66177_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25143-y","volume":"8","author":"RCM de Jong","year":"2018","unstructured":"de Jong, R. C. M. et al. Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response. Sci. Rep. 8, 6753, https:\/\/doi.org\/10.1038\/s41598-018-25143-y (2018).","journal-title":"Sci. Rep."},{"key":"66177_CR43","doi-asserted-by":"publisher","first-page":"e0190229","DOI":"10.1371\/journal.pone.0190229","volume":"12","author":"R Stohr","year":"2017","unstructured":"Stohr, R. et al. Annexin A5 reduces early plaque formation in ApoE \u2212\/\u2212 mice. PLoS One 12, e0190229, https:\/\/doi.org\/10.1371\/journal.pone.0190229 (2017).","journal-title":"PLoS One"},{"key":"66177_CR44","doi-asserted-by":"publisher","first-page":"42602","DOI":"10.18632\/oncotarget.16645","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis. Oncotarget 8, 42602\u201342612, https:\/\/doi.org\/10.18632\/oncotarget.16645 (2017).","journal-title":"Oncotarget"},{"key":"66177_CR45","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00018-007-7297-2","volume":"64","author":"H Kenis","year":"2007","unstructured":"Kenis, H., Hofstra, L. & Reutelingsperger, C. P. Annexin A5: shifting from a diagnostic towards a therapeutic realm. Cell. Mol. life sciences: CMLS 64, 2859\u20132862 (2007).","journal-title":"Cell. Mol. life sciences: CMLS"},{"key":"66177_CR46","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.01.030","volume":"1783","author":"HO van Genderen","year":"2008","unstructured":"van Genderen, H. O., Kenis, H., Hofstra, L., Narula, J. & Reutelingsperger, C. P. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim. Biophys. Acta 1783, 953\u2013963, https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.030 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"66177_CR47","first-page":"640","volume":"145","author":"DA Eberhard","year":"1994","unstructured":"Eberhard, D. A., Brown, M. D. & VandenBerg, S. R. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am. J. Pathol. 145, 640\u2013649 (1994).","journal-title":"Am. J. Pathol."},{"key":"66177_CR48","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1073\/pnas.1209362110","volume":"110","author":"E Cristante","year":"2013","unstructured":"Cristante, E. et al. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc. Natl Acad. Sci. U S Am. 110, 832\u2013841 (2013).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"66177_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0197-4580(92)90053-Z","volume":"13","author":"NW Kowall","year":"1992","unstructured":"Kowall, N. W., McKee, A. C., Yankner, B. A. & Beal, M. F. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. Neurobiol. Aging 13, 537\u2013542 (1992).","journal-title":"Neurobiol. Aging"},{"key":"66177_CR50","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1073\/pnas.90.17.7951","volume":"90","author":"DT Loo","year":"1993","unstructured":"Loo, D. T. et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl Acad. Sci. U S Am. 90, 7951\u20137955 (1993).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"66177_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.1994.tb44400.x","volume":"747","author":"CW Cotman","year":"1994","unstructured":"Cotman, C. W., Whittemore, E. R., Watt, J. A., Anderson, A. J. & Loo, D. T. Possible role of apoptosis in Alzheimer\u2019s disease. Ann. N. Y. Acad. Sci. 747, 36\u201349 (1994).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"66177_CR52","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.1523\/JNEUROSCI.16-23-07533.1996","volume":"16","author":"E Paradis","year":"1996","unstructured":"Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C. & LeBlanc, A. Amyloid beta peptide of Alzheimer\u2019s disease downregulates Bcl-2 and upregulates bax expression in human neurons. J. neuroscience: Off. J. Soc. Neurosci. 16, 7533\u20137539 (1996).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"66177_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/nbdi.2001.0386","volume":"8","author":"AR White","year":"2001","unstructured":"White, A. R. et al. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer\u2019s disease activates expression of proapoptotic markers in primary cortical neurons. Neurobiol. Dis. 8, 299\u2013316 (2001).","journal-title":"Neurobiol. Dis."},{"key":"66177_CR54","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1165\/rcmb.2013-0188OC","volume":"50","author":"DK Pillai","year":"2014","unstructured":"Pillai, D. K. et al. Directional secretomes reflect polarity-specific functions in an in vitro model of human bronchial epithelium. Am. J. respiratory Cell Mol. Biol. 50, 292\u2013300, https:\/\/doi.org\/10.1165\/rcmb.2013-0188OC (2014).","journal-title":"Am. J. respiratory Cell Mol. Biol."},{"key":"66177_CR55","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1471-4159.2007.05079.x","volume":"104","author":"F Calderon","year":"2008","unstructured":"Calderon, F. & Kim, H. Y. Detection of intracellular phosphatidylserine in living cells. J. Neurochem. 104, 1271\u20131279, https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05079.x (2008).","journal-title":"J. Neurochem."},{"key":"66177_CR56","doi-asserted-by":"publisher","first-page":"e11102","DOI":"10.1371\/journal.pone.0011102","volume":"5","author":"PA Jaeger","year":"2010","unstructured":"Jaeger, P. A. et al. Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS One 5, e11102, https:\/\/doi.org\/10.1371\/journal.pone.0011102 (2010).","journal-title":"PLoS One"},{"key":"66177_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon, R. A. et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. neuropathology Exp. Neurol. 64, 113\u2013122 (2005).","journal-title":"J. neuropathology Exp. Neurol."},{"key":"66177_CR58","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.1009485107","volume":"107","author":"MM Lipinski","year":"2010","unstructured":"Lipinski, M. M. et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. U S Am. 107, 14164\u201314169, https:\/\/doi.org\/10.1073\/pnas.1009485107 (2010).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"66177_CR59","doi-asserted-by":"publisher","unstructured":"Fedeli, C., Filadi, R., Rossi, A., Mammucari, C. & Pizzo, P. PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca(2+) homeostasis. Autophagy, 1\u201319, https:\/\/doi.org\/10.1080\/15548627.2019.1596489 (2019).","DOI":"10.1080\/15548627.2019.1596489"},{"key":"66177_CR60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3233\/jad-170216","volume":"59","author":"ZH Zhang","year":"2017","unstructured":"Zhang, Z. H. et al. Selenomethionine Attenuates the Amyloid-beta Level by Both Inhibiting Amyloid-beta Production and Modulating Autophagy in Neuron-2a\/AbetaPPswe Cells. J. Alzheimers Dis. 59, 591\u2013602, https:\/\/doi.org\/10.3233\/jad-170216 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"66177_CR61","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1023\/A:1007675508413","volume":"25","author":"RA Nixon","year":"2000","unstructured":"Nixon, R. A., Cataldo, A. M. & Mathews, P. M. The endosomal-lysosomal system of neurons in Alzheimer\u2019s disease pathogenesis: a review. Neurochem. Res. 25, 1161\u20131172 (2000).","journal-title":"Neurochem. Res."},{"key":"66177_CR62","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/jneurosci.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland, B. et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J. neuroscience: Off. J. Soc. Neurosci. 28, 6926\u20136937, https:\/\/doi.org\/10.1523\/jneurosci.0800-08.2008 (2008).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"66177_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1083\/jcb.200505082","volume":"171","author":"WH Yu","year":"2005","unstructured":"Yu, W. H. et al. Macroautophagy\u2013a novel Beta-amyloid peptide-generating pathway activated in Alzheimer\u2019s disease. J. Cell Biol. 171, 87\u201398, https:\/\/doi.org\/10.1083\/jcb.200505082 (2005).","journal-title":"J. Cell Biol."},{"key":"66177_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1242\/jcs.086728","volume":"125","author":"G Ghislat","year":"2012","unstructured":"Ghislat, G., Aguado, C. & Knecht, E. Annexin A5 stimulates autophagy and inhibits endocytosis. J. Cell Sci. 125, 92\u2013107, https:\/\/doi.org\/10.1242\/jcs.086728 (2012).","journal-title":"J. Cell Sci."},{"key":"66177_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/nbdi.2000.0364","volume":"8","author":"K Ditaranto","year":"2001","unstructured":"Ditaranto, K., Tekirian, T. L. & Yang, A. J. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer\u2019s disease. Neurobiol. Dis. 8, 19\u201331, https:\/\/doi.org\/10.1006\/nbdi.2000.0364 (2001).","journal-title":"Neurobiol. Dis."},{"key":"66177_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1247\/csf.17006","volume":"42","author":"Y Oku","year":"2017","unstructured":"Oku, Y., Murakami, K., Irie, K., Hoseki, J. & Sakai, Y. Synthesized Abeta42 Caused Intracellular Oxidative Damage, Leading to Cell Death, via Lysosome Rupture. Cell structure Funct. 42, 71\u201379, https:\/\/doi.org\/10.1247\/csf.17006 (2017).","journal-title":"Cell structure Funct."},{"key":"66177_CR67","doi-asserted-by":"publisher","unstructured":"Nixon, R. A. & Yang, D. S. Autophagy and neuronal cell death in neurological disorders. Cold Spring Harbor perspectives in biology 4, https:\/\/doi.org\/10.1101\/cshperspect.a008839 (2012).","DOI":"10.1101\/cshperspect.a008839"},{"key":"66177_CR68","doi-asserted-by":"crossref","first-page":"26107","DOI":"10.1016\/S0021-9258(19)74287-2","volume":"268","author":"PB Gordon","year":"1993","unstructured":"Gordon, P. B., Holen, I., Fosse, M., Rotnes, J. S. & Seglen, P. O. Dependence of hepatocytic autophagy on intracellularly sequestered calcium. J. Biol. Chem. 268, 26107\u201326112 (1993).","journal-title":"J. Biol. Chem."},{"key":"66177_CR69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams, A. et al. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295\u2013305, https:\/\/doi.org\/10.1038\/nchembio.79 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"66177_CR70","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1073\/pnas.90.2.567","volume":"90","author":"N Arispe","year":"1993","unstructured":"Arispe, N., Rojas, E. & Pollard, H. B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl Acad. Sci. U S Am. 90, 567\u2013571 (1993).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"66177_CR71","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1523\/JNEUROSCI.23-12-05088.2003","volume":"23","author":"AY Abramov","year":"2003","unstructured":"Abramov, A. Y., Canevari, L. & Duchen, M. R. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. neuroscience: Off. J. Soc. Neurosci. 23, 5088\u20135095 (2003).","journal-title":"J. neuroscience: Off. J. Soc. Neurosci."},{"key":"66177_CR72","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","volume":"3","author":"FM LaFerla","year":"2002","unstructured":"LaFerla, F. M. Calcium dyshomeostasis and intracellular signalling in Alzheimer\u2019s disease. Nat. reviews. Neurosci. 3, 862\u2013872 (2002).","journal-title":"Nat. reviews. Neurosci."},{"key":"66177_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola, K. L. & Klein, W. L. Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta neuropathologica 129, 183\u2013206, https:\/\/doi.org\/10.1007\/s00401-015-1386-3 (2015).","journal-title":"Acta neuropathologica"},{"key":"66177_CR74","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1096\/fasebj.14.9.1233","volume":"14","author":"R Bhatia","year":"2000","unstructured":"Bhatia, R., Lin, H. & Lal, R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB journal: Off. Publ. Federation Am. Societies Exp. Biol. 14, 1233\u20131243 (2000).","journal-title":"FASEB journal: Off. Publ. Federation Am. Societies Exp. Biol."},{"key":"66177_CR75","doi-asserted-by":"publisher","first-page":"14077","DOI":"10.1074\/jbc.275.19.14077","volume":"275","author":"M Kawahara","year":"2000","unstructured":"Kawahara, M., Kuroda, Y., Arispe, N. & Rojas, E. Alzheimer\u2019s beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077\u201314083 (2000).","journal-title":"J. Biol. Chem."},{"key":"66177_CR76","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","volume":"59","author":"KV Kuchibhotla","year":"2008","unstructured":"Kuchibhotla, K. V. et al. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59, 214\u2013225, https:\/\/doi.org\/10.1016\/j.neuron.2008.06.008 (2008).","journal-title":"Neuron"},{"key":"66177_CR77","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s &. dementia: J. Alzheimer\u2019s Assoc. 7, 263\u2013269, https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005 (2011).","journal-title":"dementia: J. Alzheimer\u2019s Assoc."},{"key":"66177_CR78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183\u2013194 (2004).","journal-title":"J. Intern. Med."},{"key":"66177_CR79","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s dementia: J. Alzheimer\u2019s Assoc. 7, 270\u2013279, https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008 (2011).","journal-title":"Alzheimer\u2019s dementia: J. Alzheimer\u2019s Assoc."},{"key":"66177_CR80","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/wnl.0000000000001859","volume":"85","author":"D Alcolea","year":"2015","unstructured":"Alcolea, D. et al. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology 85, 626\u2013633, https:\/\/doi.org\/10.1212\/wnl.0000000000001859 (2015).","journal-title":"Neurology"},{"key":"66177_CR81","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm1202-793","volume":"8","author":"E Carro","year":"2002","unstructured":"Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D. & Torres-Aleman, I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 8, 1390\u20131397 (2002).","journal-title":"Nat. Med."},{"key":"66177_CR82","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. U S Am. 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl Acad. Sci. U S Am."},{"key":"66177_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01678-4","volume":"7","author":"F Bartolome","year":"2017","unstructured":"Bartolome, F. et al. Pathogenic p62\/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. Sci. Rep. 7, 1666, https:\/\/doi.org\/10.1038\/s41598-017-01678-4 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66177-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T10:32:03Z","timestamp":1723026723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66177-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66177"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66177-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9391"}}